Skip to main content
Top
Published in: Diabetologia 3/2019

Open Access 01-03-2019 | Myocardial Infarction | Article

Trends in incidence and case fatality of acute myocardial infarction, angina and coronary revascularisation in people with and without type 2 diabetes in Scotland between 2006 and 2015

Authors: Stephanie H. Read, Colin M. Fischbacher, Helen M. Colhoun, Danijela Gasevic, Joannes J. Kerssens, David A. McAllister, Naveed Sattar, Sarah H. Wild, on behalf of the Scottish Diabetes Research Network Epidemiology Group

Published in: Diabetologia | Issue 3/2019

Login to get access

Abstract

Aims/hypothesis

The aim of the study was to examine trends in the incidence and case fatality of acute myocardial infarction (AMI) and in hospital admissions for angina and coronary revascularisation procedures in people with type 2 diabetes and in people without diabetes in Scotland between 2006 and 2015.

Methods

In this retrospective cohort study, AMI, angina and revascularisation event data were obtained for adults from hospital admissions and death records linked to a population-based diabetes register. Incidence by diabetes status was estimated using negative binomial models with adjustment or stratification by age, sex, deprivation and calendar year. Logistic regression was used to estimate AMI case fatality by diabetes status.

Results

There were 129,926 incident AMI events, 41,263 angina admissions and 69,875 coronary revascularisation procedures carried out during 34.9 million person-years of follow-up. The adjusted incidence of AMI, angina and revascularisation procedures declined by 2.0% (95% CI 1.73%, 2.26%), 9.62% (95% CI 9.22%, 10.01%) and 0.35% (95% CI −0.09%, 0.79%) per year, respectively. The rate of decline did not differ materially by diabetes status. RRs of AMI for type 2 diabetes were 1.86 (95% CI 1.74, 1.98) for men and 2.32 (95% CI 2.15, 2.51) for women. Of the 77,211 people admitted to hospital with a first AMI, 7842 (10.2%) died within 30 days of admission. Case fatality was higher in people with type 2 diabetes than in people without diabetes and declined in both groups by 7.93% (95% CI 7.03%, 8.82%) per year.

Conclusions/interpretation

The incidence of AMI, angina, revascularisation and AMI case fatality has declined over time, but the increased risk associated with type 2 diabetes has remained approximately constant.
Appendix
Available only for authorised users
Literature
11.
go back to reference Kendrick S, Clarke J (1993) The Scottish record linkage system. Health Bull 51:72–79 Kendrick S, Clarke J (1993) The Scottish record linkage system. Health Bull 51:72–79
12.
go back to reference Kendrick SW, Douglas MM, Gardner D, Hucker D (1998) Best-link matching of Scottish health data sets. Methods Inf Med 37(1):64–68CrossRef Kendrick SW, Douglas MM, Gardner D, Hucker D (1998) Best-link matching of Scottish health data sets. Methods Inf Med 37(1):64–68CrossRef
18.
go back to reference Icks A, Dickhaus T, Hormann A et al (2009) Differences in trends in estimated incidence of myocardial infarction in non-diabetic and diabetic people: Monitoring Trends and Determinants on Cardiovascular Diseases (MONICA)/Cooperative Health Research in the Region of Augsburg (KORA) registry. Diabetologia 52(9):1836–1841. https://doi.org/10.1007/s00125-009-1434-4 CrossRefPubMed Icks A, Dickhaus T, Hormann A et al (2009) Differences in trends in estimated incidence of myocardial infarction in non-diabetic and diabetic people: Monitoring Trends and Determinants on Cardiovascular Diseases (MONICA)/Cooperative Health Research in the Region of Augsburg (KORA) registry. Diabetologia 52(9):1836–1841. https://​doi.​org/​10.​1007/​s00125-009-1434-4 CrossRefPubMed
23.
go back to reference Hotchkiss JW, Davies CA, Dundas R et al (2014) Explaining trends in Scottish coronary heart disease mortality between 2000 and 2010 using IMPACTSEC model: retrospective analysis using routine data. BMJ g1088:348 Hotchkiss JW, Davies CA, Dundas R et al (2014) Explaining trends in Scottish coronary heart disease mortality between 2000 and 2010 using IMPACTSEC model: retrospective analysis using routine data. BMJ g1088:348
25.
go back to reference Campbell-Jack D, Hinchcliffe S, Rutherford L (eds) (2016) The Scottish Health Survey. A national statistics publication for Scotland, vol 1, 2015 edn. The Scottish Government, Edinburgh Campbell-Jack D, Hinchcliffe S, Rutherford L (eds) (2016) The Scottish Health Survey. A national statistics publication for Scotland, vol 1, 2015 edn. The Scottish Government, Edinburgh
26.
go back to reference Scottish Diabetes Survey Monitoring Group (2016) Scottish Diabetes Survey 2015. NHS Scotland, Edinburgh Scottish Diabetes Survey Monitoring Group (2016) Scottish Diabetes Survey 2015. NHS Scotland, Edinburgh
28.
go back to reference Herman WH, Ye W, Griffin SJ et al (2015) Early detection and treatment of type 2 diabetes reduce cardiovascular morbidity and mortality: a simulation of the results of the Anglo-Danish-Dutch Study of Intensive Treatment in People With Screen-Detected Diabetes in Primary Care (ADDITION-Europe). Diabetes Care 38(8):1449–1455. https://doi.org/10.2337/dc14-2459 CrossRefPubMedPubMedCentral Herman WH, Ye W, Griffin SJ et al (2015) Early detection and treatment of type 2 diabetes reduce cardiovascular morbidity and mortality: a simulation of the results of the Anglo-Danish-Dutch Study of Intensive Treatment in People With Screen-Detected Diabetes in Primary Care (ADDITION-Europe). Diabetes Care 38(8):1449–1455. https://​doi.​org/​10.​2337/​dc14-2459 CrossRefPubMedPubMedCentral
29.
go back to reference Shah ASV, Griffiths M, Lee KK et al (2015) High sensitivity cardiac troponin and the under-diagnosis of myocardial infarction in women: prospective cohort study. BMJ g7873:350 Shah ASV, Griffiths M, Lee KK et al (2015) High sensitivity cardiac troponin and the under-diagnosis of myocardial infarction in women: prospective cohort study. BMJ g7873:350
Metadata
Title
Trends in incidence and case fatality of acute myocardial infarction, angina and coronary revascularisation in people with and without type 2 diabetes in Scotland between 2006 and 2015
Authors
Stephanie H. Read
Colin M. Fischbacher
Helen M. Colhoun
Danijela Gasevic
Joannes J. Kerssens
David A. McAllister
Naveed Sattar
Sarah H. Wild
on behalf of the Scottish Diabetes Research Network Epidemiology Group
Publication date
01-03-2019
Publisher
Springer Berlin Heidelberg
Published in
Diabetologia / Issue 3/2019
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-018-4796-7

Other articles of this Issue 3/2019

Diabetologia 3/2019 Go to the issue

Up Front

Up front

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.